Related Experiment Video
Updated: Feb 13, 2026

Isolation of Human Endothelial Cells from Normal Colon and Colorectal Carcinoma - An Improved Protocol
Published on: April 4, 2018
Targeting a Sirt5-Positive Subpopulation Overcomes Multidrug Resistance in Wild-Type Kras Colorectal Carcinomas
ZunGuo Du1, XiuJuan Liu2, Tao Chen3
1Department of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China; Department of Pathology, HuaShan Hospital, Fudan University, Shanghai 200040, China.
Abstract:
A major obstacle for successful management of patients with colorectal carcinoma (CRC) is resistance to anti-cancer cytotoxic treatments. Here, we identified a mechanism of multidrug resistance in wild-type Kras CRCs based on the survival of a cell subpopulation characterized by Sirt5 expression. Sirt5+ cells in wild-type Kras CRCs are resistant to either chemotherapeutic agents or cetuximab and serve as a reservoir for recurrence. Sirt5 demalonylates and inactivates succinate dehydrogenase complex subunit A (SDHA), leading to an accumulation of the oncometabolite succinate. Succinate binds to and activates a reactive oxygen species-scavenging enzyme, thioredoxin reductase 2 (TrxR2), to confer chemotherapy resistance. In contrast, Sirt5+ cells exhibit an elevated succinate-to-aKG ratio that inhibits aKG-dependent dioxygenases to maintain cetuximab resistance. Our findings suggest that Sirt5 inhibitors in combination with chemotherapeutic agents and/or cetuximab may represent a therapeutic strategy for CRC patients harboring wild-type Kras.
Insights
A novel mechanism of multidrug resistance in colorectal cancer (CRC) involves Sirt5-expressing cells. These cells, fueled by succinate accumulation, resist chemotherapy and cetuximab, potentially driving recurrence.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Multidrug resistance (MDR) is a significant challenge in colorectal cancer (CRC) management.
- A subpopulation of cells expressing Sirt5 contributes to treatment resistance in wild-type Kras CRC.
- These Sirt5-expressing cells act as a reservoir for cancer recurrence.
Purpose of the Study:
- To elucidate the mechanism of multidrug resistance mediated by Sirt5 in wild-type Kras colorectal carcinoma.
- To identify the metabolic pathways and molecular interactions involved in Sirt5-driven resistance.
- To explore potential therapeutic strategies targeting Sirt5 for CRC treatment.
Main Methods:
- Analysis of Sirt5 expression in wild-type Kras CRC patient samples.
- Investigating the enzymatic activity of Sirt5, including its interaction with succinate dehydrogenase complex subunit A (SDHA).
- Assessing the role of succinate accumulation and its downstream effects on reactive oxygen species (ROS) scavenging and enzyme activity.
Main Results:
- Sirt5 demalonylates and inactivates SDHA, leading to succinate accumulation.
- Accumulated succinate activates thioredoxin reductase 2 (TrxR2), conferring resistance to chemotherapeutic agents.
- Sirt5+ cells exhibit an elevated succinate-to-alpha-ketoglutarate (aKG) ratio, inhibiting aKG-dependent dioxygenases and conferring cetuximab resistance.
Conclusions:
- Sirt5-expressing cells are a key driver of resistance to chemotherapy and cetuximab in wild-type Kras CRC.
- The identified Sirt5-mediated metabolic reprogramming provides a survival advantage to cancer cells.
- Targeting Sirt5 in combination with standard therapies may offer a novel therapeutic approach for CRC patients with wild-type Kras.
More Related Videos
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
23:06The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Related Concept Videos
Types of Global Positioning System Surveys
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
Position-effect Variegation
Positive Regulator Molecules
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Resistivity